---
title: "Metagenomi director Laurence Reid acquires common shares worth $23,403.95"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298776557.md"
description: "Metagenomi Therapeutics director Laurence Reid purchased 20,000 common shares in open-market transactions priced between $1.17 and $1.18, totaling approximately $23,403.95. Following these acquisitions, his directly held stake increased to 20,000 shares. The transaction was reported via EDGAR on September 11, 2026."
datetime: "2026-09-11T23:52:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298776557.md)
  - [en](https://longbridge.com/en/news/298776557.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298776557.md)
generator: "portal-rs"
---

# Metagenomi director Laurence Reid acquires common shares worth $23,403.95

-   Director Laurence Reid bought 20,000 Metagenomi Therapeutics common shares in open-market purchases priced around $1.17-$1.18. \* Directly held stake rose to 20,000 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metagenomi Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-389550), on September 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MGX.US](https://longbridge.com/en/quote/MGX.US.md)

## Related News & Research

- [Metagenomi CEO to join Wells Fargo Healthcare Conference fireside chat](https://longbridge.com/en/news/297649047.md)
- [Nebius COO Nave Ophir disposes of USD 113.38 million in Class A shares](https://longbridge.com/en/news/301073075.md)
- [Personalis-Tempus AI deal clears US antitrust waiting period under HSR Act](https://longbridge.com/en/news/301072040.md)
- [LIVE MARKETS-TSMC earnings could cause another round of consensus upgrades](https://longbridge.com/en/news/301145455.md)
- [Palantir vs. Oracle – Why Daniel Ives Says Buy One, Hold the Other](https://longbridge.com/en/news/301155464.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**